Viewing Study NCT03813160


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-02-22 @ 10:15 AM
Study NCT ID: NCT03813160
Status: COMPLETED
Last Update Posted: 2022-08-16
First Post: 2019-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Sponsor: Corbus Pharmaceuticals Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dermatomyositis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None dermatomyositis View
None cannabinoid receptor type 2 agonist View
None JBT-101 View
None lenabasum View